Answers are grounded in this paper and cite their sources.
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare acquired genetic defect of the hematopoietic stem cell characterized by a triad of hemolytic anemia, pancytopenia, and thrombosis. Cutaneous thrombosis is a rare manifestation of this disease. Herein, we report a case of a patient with PNH whose first and only symptom was localized severe cutaneous thrombosis with hemorrhagic necrosis. During the diagnostic workup, it was necessary to exclude possible causes of chronic hemolysis without anemia and also to perform the confirmatory genetic test. The patient was discharged anticoagulated and with a recommendation for oral corticosteroids at weaning until initiating targeted therapy with eculizumab. To date, only 15 cases of PNH-associated cutaneous thrombosis have been documented worldwide. This paper focuses on highlighting and describing a rare manifestation of this disease and reviewing the existing literature.
No takes yet. Share an insight, caveat, or question.
Silva et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: